He lost me when he started trying to comp the valuation to Unilever. Pre GLP-1 sales 2020 to 2023 went from 150M to 900M. Profit trajectory is similar. And you want to comp a multiple to Unilever? Okay.
Hims non glp growth will magically fall off of a cliff because of "saturation"? Okay.
And like everyone else, the guest assumes their weight loss business can't survive without glp-1 even though management has stated that personalized doses make up only a small portion of 2025 guidance.
He lost me when he started trying to comp the valuation to Unilever. Pre GLP-1 sales 2020 to 2023 went from 150M to 900M. Profit trajectory is similar. And you want to comp a multiple to Unilever? Okay.
Hims non glp growth will magically fall off of a cliff because of "saturation"? Okay.
And like everyone else, the guest assumes their weight loss business can't survive without glp-1 even though management has stated that personalized doses make up only a small portion of 2025 guidance.